Signe Friesland

Karolinska University Hospital

Sweden

Research Interests

Explore related searches

Professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (17)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (8)

Eva Onjukka

Karolinska University Hospital

SWEDEN

View details

Anders Näsman

Karolinska University Hospital

SWEDEN

View details

Tina Dalianis

Karolinska Institutet

SWEDEN

View details

Martin Bengtsson

Lund University

SWEDEN

View details

Anna Embring

Karolinska Institutet

SWEDEN

View details

Helena Ullgren

Karolinska Institutet

SWEDEN

View details

Mathias von Beckerath

Karolinska University Hospital

SWEDEN

View details

Lalle Hammarstedt-Nordenvall

Karolinska Institutet

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Signe Friesland

Research Interests

Explore related searches

Contact this professor

Articles (17)

Adenoid Cystic Carcinoma, Clinical Presentation, Current Treatment and Approaches Towards Novel Therapies

Brachytherapy and osteoradionecrosis in patients with base of tongue cancer

Dose Escalation of Oropharyngeal Cancer: Long-Time Follow-Up and Side Effects

Adenoid Cystic Carcinoma (AdCC): A Clinical Survey of a Large Patient Cohort

Radiotherapy—Dose Escalated for Large Volume Primary Tumors—And Cetuximab with or without Induction Chemotherapy for HPV Associated Squamous Cell Carcinoma of the Head and Neck—A Randomized Phase II Trial

Adenoid Cystic Carcinoma (AdCC): A Clinical Survey of a Large Patient Cohort

Dose Escalation of Oropharyngeal Cancer: Long-Time Follow-Up and Side Effects

Dose escalation in oropharyngeal cancer: a comparison of simultaneous integrated boost and brachytherapy boost

Radiotherapy-Dose Escalated for Large Volume Primary Tumors-And Cetuximab with or without Induction Chemotherapy for HPV Associated Squamous Cell Carcinoma of the Head and Neck-A Randomized Phase II Trial

Analysis of Human Papillomavirus (HPV) and Polyomaviruses (HPyVs) in Adenoid Cystic Carcinoma (AdCC) of the Head and Neck Region Reveals Three HPV-Positive Cases with Adenoid Cystic-like Features

Re-Irradiation for Head and Neck Cancer: Cumulative Dose to Organs at Risk and Late Side Effects

Long-Term Survival and Recurrence in Oropharyngeal Squamous Cell Carcinoma in Relation to Subsites, HPV, and p16-Status

Clinical characteristics and factors associated with COVID-19-related death and morbidity among hospitalized patients with cancer: a Swedish cohort study

Effect of corticosteroids on the outcome of patients with advanced non-small cell lung cancer treated with immune-checkpoint inhibitors.

Modeling of Xerostomia After Radiotherapy for Head and Neck Cancer: A Registry Study.

ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer.

Randomized Phase II Study with Cetuximab in Combination with 5-FU and Cisplatin or Carboplatin vs. Cetuximab in Combination with Paclitaxel and Carboplatin for Treatment of Patients with Relapsed or Metastatic Squamous Cell Carcinoma of the Head and Neck (CETMET Trial).

Collaborators (8)

Eva Onjukka

Anders Näsman

Tina Dalianis

Martin Bengtsson

Anna Embring

Helena Ullgren

Mathias von Beckerath

Lalle Hammarstedt-Nordenvall

Make your next move.